Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.

Bouquet F, Pal A, Pilones KA, Demaria S, Hann B, Akhurst RJ, Babb JS, Lonning SM, DeWyngaert JK, Formenti SC, Barcellos-Hoff MH.

Clin Cancer Res. 2011 Nov 1;17(21):6754-65. doi: 10.1158/1078-0432.CCR-11-0544. Epub 2011 Oct 25.

2.

Inhibiting breast cancer progression by exploiting TGFbeta signaling.

Baxley SE, Serra R.

Curr Drug Targets. 2010 Sep;11(9):1089-102. Review.

PMID:
20545612
3.

Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?

Tan AR, Alexe G, Reiss M.

Breast Cancer Res Treat. 2009 Jun;115(3):453-95. doi: 10.1007/s10549-008-0184-1. Epub 2008 Oct 9. Review.

4.

Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas.

Du S, Barcellos-Hoff MH.

Semin Radiat Oncol. 2013 Oct;23(4):242-51. doi: 10.1016/j.semradonc.2013.05.001. Review.

5.

Targeting the TGFβ signalling pathway in disease.

Akhurst RJ, Hata A.

Nat Rev Drug Discov. 2012 Oct;11(10):790-811. doi: 10.1038/nrd3810. Epub 2012 Sep 24. Review.

6.

Transforming growth factor-beta in breast cancer: too much, too late.

Barcellos-Hoff MH, Akhurst RJ.

Breast Cancer Res. 2009;11(1):202. doi: 10.1186/bcr2224. Epub 2009 Feb 26. Review.

Supplemental Content

Support Center